Why Zymeworks Inc. (ZYME) stock fell 7.6% on Wednesday, November 11, 2026
Zymeworks Inc. (ZYME) closed at $29.07, down 7.60% on Wednesday, November 11, 2026, on volume of 897,472 shares (0.9× its 3-month average); market value about $2.00B, according to Nexqual market data (nexqual.com/moves/2026-11-11/ZYME).
What happened: primary sources
Events Nexqual found for ZYME on Wednesday, November 11, 2026 or the trading day before (November 10, 2026), each linked to its primary source:
- Nov 11, 2026: Citigroup: Target raised, Buy, price target $39 → $44
- Nov 10, 2026: TD Cowen: Target raised, Buy, price target $34 → $39
- Nov 10, 2026: Truist Securities: Target raised, Buy, price target $35 → $36
- Nov 10, 2026: HC Wainwright & Co.: Target raised, Buy, price target $55 → $56
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on ZYME
ZYME stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 11, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:53 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt